Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine plus Paclitaxel vs Paclitaxel in Advanced Breast Cancer
NCT00006459Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine in breast cancer, sponsored by Eli Lilly and Company. Started Jul 2000; status: completed.
02
Drugs
gemcitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00006459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006459.